Press release
End Stage Renal Disease (ESRD) Drug Market: Soaring to $149.88 Billion in 2025, Trends, and Major Players
End Stage Renal Disease (ESRD) Drug Market Share
What Is The Projected Market Size Of The Global End Stage Renal Disease (ESRD) Drug Market And Its Growth Rate?
The global ESRD drug market has experienced notable growth recently:
• 2024 Market Size: $131.41 Billion
• 2025 Projected Market Size: $149.88 Billion (CAGR: 14.1%)
• 2029 Projected Market Size: $268.44 Billion (CAGR: 15.7%)
The market growth can be attributed to the rising incidence of ESRD, advancements in treatment modalities, growing emphasis on precision medicine, and the development of combination therapies.
What Is Driving The Growth In The End Stage Renal Disease (ESRD) Drug Market?
The main drivers propelling the ESRD drug market forward include the escalating cases of obesity and diabetes. In obese patients, managing fluid and electrolyte levels through dialysis can lead to weight reduction. Also, according to the World Obesity, the number of obese people is expected to rise to 1,025 million by 2030. Meanwhile, the National Health Service predicts that the population of people in the UK with diabetes could reach 5.5 million by 2030, impacting almost 9% of the population.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9437&type=smp
Who Are the Key Players Driving End Stage Renal Disease (ESRD) Drug Market Growth?
The ESRD drug market has seen significant contributions from key players such as:
• Pfizer Inc.
• AstraZeneca plc
• Sanofi SA
• Astellas Pharma Inc.
• Novartis AG
• Fresenius SE & Co. KGaA
• Takeda Pharmaceutical Company Limited
• F. Hoffmann-La Roche Ltd.
• Kissei Pharmaceutical Co. Ltd.
• Baxter International Inc.
• AbbVie Inc.
• Amgen Inc.
• Akebia Drugs Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• B. Braun SE
• Asahi Kasei Medical Co. Ltd.
• Nikkiso Co. Ltd.
• Abbott Laboratories
• Merck Co. & KGaA
What Are The Key Trends In The End Stage Renal Disease (ESRD) Drug Market?
Several trends have become prominent in the ESRD drug market:
• Increasing incidence of end stage renal disease
• Advancements in treatment modalities
• Growing emphasis on precision medicine
• Development of combination therapies
• Technological integration in healthcare
What Are The Segments Of The Global End Stage Renal Disease (ESRD) Drug Market?
The ESRD drug market is categorized into the following segments:
• By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products
• By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia
• By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
• By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Which Region Leads The End Stage Renal Disease (ESRD) Drug Market?
Among all the regions, North America held the largest share in the ESRD drug market in 2024. This dominance can be attributed to factors like advanced healthcare infrastructure, expanded access to healthcare services, and government initiatives for kidney disease management.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/end-stage-renal-disease-esrd-drug-global-market-report
What Is Covered In The End Stage Renal Disease (ESRD) Drug Market Global Market Report?
- Market Size Analysis: Analyze the End Stage Renal Disease (ESRD) Drug Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the End Stage Renal Disease (ESRD) Drug Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall End Stage Renal Disease (ESRD) Drug Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the End Stage Renal Disease (ESRD) Drug Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=9437&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release End Stage Renal Disease (ESRD) Drug Market: Soaring to $149.88 Billion in 2025, Trends, and Major Players here
News-ID: 3826362 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for ESRD
Driving End Stage Renal Disease (ESRD) Drug Market Growth in 2025: The Role of T …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
End Stage Renal Disease (ESRD) Drug Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs treating end stage renal disease (ESRD) has seen a quick expansion in the recent past. The market, which was valued at $131.41 billion in 2024, is forecasted to reach $149.88 billion in 2025, displaying…
End Stage Renal Disease (ESRD) Drug Industry Report 2025-2034: Market Dynamics, …
The End Stage Renal Disease (ESRD) Drug Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current End Stage Renal Disease (ESRD) Drug Market Size and Its Estimated Growth Rate?
The market size for end-stage renal disease (ESRD) medications has witnessed a rapid upsurge…
End Stage Renal Disease (ESRD) Drug Market Report 2024 - End Stage Renal Disease …
"The Business Research Company recently released a comprehensive report on the Global End Stage Renal Disease (ESRD) Drug Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
End-Stage Renal Disease (ESRD) Market Share, Revenue, Prospects and Forecast 202 …
In recent years, the global End-Stage Renal Disease (ESRD) Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on End-Stage Renal Disease (ESRD) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business…
End Stage Renal Disease (ESRD) Drug Market Size, Share, and Scope 2033
The new report published by The Business Research Company, titled ""End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the end stage renal disease (esrd) drug market size has grown rapidly in recent years.…
End Stage Renal Disease (ESRD) Drug Market 2024-2033: Trends, Analysis & Growth …
The end stage renal disease (esrd) drug market size has grown rapidly in recent years. It will grow from $116.32 billion in 2023 to $132.86 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing incidence of end stage renal disease, growing aging population, improved access to healthcare services, government initiatives and policies, increasing adoption…
